Quantcast

Future of targeted therapy and genomic profiling

Annie Martin, Global Head of Presicion Medicine, has discussed the future of targeted therapy and genomic profiling, describing how to profile tumors with RNA and DNA sequencing.

Source: Novartis

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.